The role and mechanism of HMGB1 improving the chemosensitivity of gemcitabine-resistant pancreatic cancer PANC1 cells
Dewen Lu, Xianpeng Li, Bo Zhang, Yuhua Jiang, Feng Xu
Abstract
Dewen Lu, Xianpeng Li, Bo Zhang, Yuhua Jiang, Feng Xu
Abstract
Objective To investigate the role and potential mechanism of high mobility group box-1 protein (HMGB1) on improving the chemosensitivity of gemcitabine-resistant pancreatic cancer PANC1 cells. Methods Gemcitabine-resistant pancreatic cancer PANC1 (PANC1-GR) cell line was established by using increased gradient concentration of gemcitabine. The si-HMGB1-PANC1 and si-HMGB1-PANC1-GR cells were established by the transfection with HMGB1 siRNA using liposome. The 50% inhibitory concentration (IC50) and Resistance index (RI) of gemcitabine in 4 PANC1 cell lines with or without HMGB1 siRNA transfection were determined and calculated by CCK-8 assay. Western blot assay was used to detect the protein expression of HMGB1 in PANC1 and PANC1-GR cells and the expression of autophagy marker protein Beclin1 in the 4 PANC1 cell lines. Flow cytometry assay was used to evaluate the apoptosis rate of 4 pancreatic caner cell lines. Results The gemcitabine-resistant pancreatic cancer cell line PANC1-GR was successfully established, which could grow stably and passage in media with 100 μmol/L gemcitabine. The IC50 of gemcitabine in PANC1, PANC1-GR, si-HMGB1-PANC1, and si-HMGB1-PANC1-GR cells lines were (4.7±0.4)μmol/L, (166.5±13.6)μmol/L, (3.2±0.3)μmol/L, and (52.4±8.4)μmol/L, respectively. The IC50 in PANC1-GR was significantly higher than that in PANC1, while the IC50 in the transfected cells was significantly lower than that in untransfected cells, and the differences were both statistically significant (both P<0.01). The RI value of gemcitabine in transfected and untransfected PANC1-GR cells was 35.4 and 16.4. The relative protein levels of HMGB1 in PANC1 and PANC1-GR were 0.17±0.08 and 0.38±0.11. The expression of HMGB1 in PANC1-GR was obviously higher than that in PANC1, and the difference was statistically significant (P<0.01). The relative protein levels of Beclin1 in PANC1, PANC1-GR, si-HMGB1-PANC1 and si-HMGB1-PANC1-GR cells were 2.68±0.23, 3.28±0.15, 0.68±0.23 and 0.78±0.11, which in two transfected cells was greatly lower than those in untransfected cells. The apoptosis level was (34.58±3.14)%, (79.56±3.58)%, (19.41±1.53)%, and (34.57±2.94)%. The apoptosis level in the 2 transfected cell lines were significantly higher than those in the 2 untransfected cell lines, and the differences were both statistically significant (P<0.01). Conclusions The inhibition of HMGB1 could improve the chemosensitivity of gemcitabine in pancreatic cancer PANC1 cells, which might be mediated by the activation of autophagy. Key words: Pancreatic neoplasms; Cell line, tumor; High mobility group proteins; Autophagy; Apoptosis; Gemcitabine
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the role and potential mechanism of high mobility group box-1 protein (HMGB1) on improving the chemosensitivity of gemcitabine-resistant pancreatic cancer PANC1 cells. Methods Gemcitabine-resistant pancreatic cancer PANC1 (PANC1-GR) cell line was established by using increased gradient concentration of gemcitabine. The si-HMGB1-PANC1 and si-HMGB1-PANC1-GR cells were established by the transfection with HMGB1 siRNA using liposome. The 50% inhibitory concentration (IC50) and Resistance index (RI) of gemcitabine in 4 PANC1 cell lines with or without HMGB1 siRNA transfection were determined and calculated by CCK-8 assay. Western blot assay was used to detect the protein expression of HMGB1 in PANC1 and PANC1-GR cells and the expression of autophagy marker protein Beclin1 in the 4 PANC1 cell lines. Flow cytometry assay was used to evaluate the apoptosis rate of 4 pancreatic caner cell lines. Results The gemcitabine-resistant pancreatic cancer cell line PANC1-GR was successfully established, which could grow stably and passage in media with 100 μmol/L gemcitabine. The IC50 of gemcitabine in PANC1, PANC1-GR, si-HMGB1-PANC1, and si-HMGB1-PANC1-GR cells lines were (4.7±0.4)μmol/L, (166.5±13.6)μmol/L, (3.2±0.3)μmol/L, and (52.4±8.4)μmol/L, respectively. The IC50 in PANC1-GR was significantly higher than that in PANC1, while the IC50 in the transfected cells was significantly lower than that in untransfected cells, and the differences were both statistically significant (both P<0.01). The RI value of gemcitabine in transfected and untransfected PANC1-GR cells was 35.4 and 16.4. The relative protein levels of HMGB1 in PANC1 and PANC1-GR were 0.17±0.08 and 0.38±0.11. The expression of HMGB1 in PANC1-GR was obviously higher than that in PANC1, and the difference was statistically significant (P<0.01). The relative protein levels of Beclin1 in PANC1, PANC1-GR, si-HMGB1-PANC1 and si-HMGB1-PANC1-GR cells were 2.68±0.23, 3.28±0.15, 0.68±0.23 and 0.78±0.11, which in two transfected cells was greatly lower than those in untransfected cells. The apoptosis level was (34.58±3.14)%, (79.56±3.58)%, (19.41±1.53)%, and (34.57±2.94)%. The apoptosis level in the 2 transfected cell lines were significantly higher than those in the 2 untransfected cell lines, and the differences were both statistically significant (P<0.01). Conclusions The inhibition of HMGB1 could improve the chemosensitivity of gemcitabine in pancreatic cancer PANC1 cells, which might be mediated by the activation of autophagy. Key words: Pancreatic neoplasms; Cell line, tumor; High mobility group proteins; Autophagy; Apoptosis; Gemcitabine
Key concepts: Gemcitabine, Transfection, Pancreatic cancer, Cell culture, Flow cytometry, Chemistry, Viability assay, Materials science